Legal & General Group’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $573K | Sell |
79,054
-14,931
| -16% | -$195K | ﹤0.01% | 2322 |
|
|
2025
Q4 | $1.6M | Sell |
93,985
-7,931
| -8% | -$80.6K | ﹤0.01% | 2064 |
|
|
2025
Q3 | $746K | Sell |
101,916
-134
| -0.1% | -$1.08K | ﹤0.01% | 2326 |
|
|
2025
Q2 | $663K | Sell |
102,050
-13,962
| -12% | -$92.2K | ﹤0.01% | 2366 |
|
|
2025
Q1 | $938K | Sell |
116,012
-2,642
| -2% | -$28.9K | ﹤0.01% | 2210 |
|
|
2024
Q4 | $1.47M | Buy |
118,654
+31,193
| +36% | +$416K | ﹤0.01% | 2110 |
|
|
2024
Q3 | $717K | Buy |
87,461
+5,350
| +7% | +$32K | ﹤0.01% | 2348 |
|
|
2024
Q2 | $410K | Buy |
82,111
+10,959
| +15% | +$62.5K | ﹤0.01% | 2482 |
|
|
2024
Q1 | $439K | Buy |
71,152
+21,796
| +44% | +$109K | ﹤0.01% | 2477 |
|
|
2023
Q4 | $249K | Buy |
49,356
+44,618
| +942% | +$238K | ﹤0.01% | 2666 |
|
|
2023
Q3 | $27.2K | Sell |
4,738
-965
| -17% | -$4.41K | ﹤0.01% | 2942 |
|
|
2023
Q2 | $20.8K | Buy |
+5,703
| New | +$23K | ﹤0.01% | 3099 |
|
|
2022
Q2 | – | Sell |
-4,355
| Closed | -$9K | – | 3672 |
|
|
2022
Q1 | $9K | Hold |
4,355
| – | – | ﹤0.01% | 3434 |
|
|
2021
Q4 | $14K | Buy |
4,355
+425
| +11% | +$1.76K | ﹤0.01% | 3391 |
|
|
2021
Q3 | $19K | Sell |
3,930
-19,821
| -83% | -$120K | ﹤0.01% | 3297 |
|
|
2021
Q2 | $158K | Buy |
23,751
+17,705
| +293% | +$116K | ﹤0.01% | 2598 |
|
|
2021
Q1 | $34K | Sell |
6,046
-188
| -3% | -$1.81K | ﹤0.01% | 2956 |
|
|
2020
Q4 | $49K | Buy |
6,234
+842
| +16% | +$7.07K | ﹤0.01% | 2809 |
|
|
2020
Q3 | $46K | Sell |
5,392
-615
| -10% | -$6.74K | ﹤0.01% | 2724 |
|
|
2020
Q2 | $63K | Buy |
6,007
+133
| +2% | +$1.25K | ﹤0.01% | 2667 |
|
|
2020
Q1 | $55K | Sell |
5,874
-1,088
| -16% | -$9.27K | ﹤0.01% | 2565 |
|
|
2019
Q4 | $56K | Buy |
6,962
+731
| +12% | +$17.9K | ﹤0.01% | 2772 |
|
|
2019
Q3 | $128K | Buy |
6,231
+1,800
| +41% | +$41.3K | ﹤0.01% | 2454 |
|
|
2019
Q2 | $116K | Buy |
4,431
+460
| +12% | +$12.9K | ﹤0.01% | 2482 |
|
|
2019
Q1 | $154K | Buy |
3,971
+877
| +28% | +$35.6K | ﹤0.01% | 2382 |
|
|
2018
Q4 | $130K | Buy |
3,094
+469
| +18% | +$20.9K | ﹤0.01% | 2401 |
|
|
2018
Q3 | $131K | Hold |
2,625
| – | – | ﹤0.01% | 2435 |
|
|
2018
Q2 | $100K | Buy |
2,625
+521
| +25% | +$22.4K | ﹤0.01% | 2503 |
|
|
2018
Q1 | $84K | Sell |
2,104
-797
| -27% | -$33.5K | ﹤0.01% | 2526 |
|
|
2017
Q4 | $101K | Sell |
2,901
-895
| -24% | -$26.1K | ﹤0.01% | 2576 |
|
|
2017
Q3 | $83K | Buy |
3,796
+645
| +20% | +$13K | ﹤0.01% | 2737 |
|
|
2017
Q2 | $60K | Buy |
3,151
+684
| +28% | +$14.7K | ﹤0.01% | 2860 |
|
|
2017
Q1 | $68K | Sell |
2,467
-65
| -3% | -$1.81K | ﹤0.01% | 2752 |
|
|
2016
Q4 | $68K | Buy |
+2,532
| New | +$82.4K | ﹤0.01% | 2775 |
|
Other funds holding WVE
RCM
GP
MC
DCM
6CM
Legal & General Group's WVE Position: Q1 2026 in Review
Legal & General Group reduced its Wave Life Sciences (WVE) stake by 16% in Q1 2026, selling an estimated $195K and leaving 79,054 shares worth $573K. The position accounts for ﹤0.01% of the portfolio, ranked #2322.
Legal & General Group first reported a position in WVE in Q4 2016 and has held it in 34 quarters since. The position peaked at $1.6M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.
- Legal & General Group held 79,054 shares of Wave Life Sciences worth $573K as of Q1 2026.
- Legal & General Group sold 14,931 Wave Life Sciences shares in Q1 2026, an estimated $195K.
- Wave Life Sciences made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2322 holding.
- Legal & General Group first reported a position in Wave Life Sciences in Q4 2016 and has held it in 34 quarters since.
- Legal & General Group's Wave Life Sciences position peaked at $1.6M in Q4 2025.
- 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.